title: [Parenchymal thoracic endometriosis--diagnosis and therapy].
abstract: We report a case of parenchymal pulmonary endometriosis in combination with severe endometriosis genitalis externa. The difficulties on the way to final diagnosis are described, also the different possibilities of hormonal treatment that results in ovarian suppression. In our case the patient is without any symptoms since three years using a GnRH-Agonist as first line therapy and as second line therapy high-dose medroxyprogesterone acetate. Because of the very good clinical results after hormonal suppression surgical intervention might become necessary only in certain cases. This can be the case when after intolerance of hormonal treatment angiography of lung vascular system on the bases of number and localization of endometrial lesions shows good operative conditions.
authors.affiliation: Zentrum für Frauenheilkunde. Abteilung für Gynäkologie, insbesondere gynäkologische Onkologie, Universitätsklinikum Essen.
authors.forename: M
authors.initials: M
authors.lastname: Schwack
authors.forename: M
authors.initials: M
authors.lastname: Montag
authors.forename: A E
authors.initials: AE
authors.lastname: Schindler
mesh_terms: D000328:Adult; D000792:Angiography; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D005187:Fallopian Tubes / Q000473:pathology; D005260:Female; D006469:Hemoptysis / Q000209:etiology; D006801:Humans; D010535:Laparoscopy; D016729:Leuprolide / Q000008:administration & dosage; D008171:Lung Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017258:Medroxyprogesterone Acetate; D016729:Leuprolide